SPOTLIGHT -
Dr. Harvey Discusses Preventing Breast Cancer
Dr. Harold Harvey from Penn State Hershey Cancer Institute Discusses Preventing Breast Cancer
Read More
Dr. Harvey on Aromatase Inhibitor Treatment Duration
Dr. Harold Harvey from Penn State Hershey Cancer Institute on Aromatase Inhibitor Treatment Duration
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
